Results 11 to 20 of about 77,631 (288)
Disease-Duration-Specific Percentiles for Prospective Subtyping of Parkinson's Disease: A PPMI-Based Study. [PDF]
Mov Disord Clin PractAbstract Background Parkinson's disease (PD) is clinically heterogeneous, with variable progression rates that complicate clinical trial design. The data‐driven diffuse malignant (DM), intermediate (IM), and mild‐motor predominant (MMP) subtyping model has prognostic value but lacks disease duration–specific thresholds for prospective use in disease ...
Negida A +4 more
europepmc +2 more sources
, 2023 Supplemental material, sj-docx-2-aut-10.1177_13623613221143587 for Community-guided measurement-based care for autistic youth and adults receiving psychotherapy: A conceptual overview and pilot implementation study of MBC-AUT by Jessica M Schwartzman ...
Zachary J Williams (10907514) +4 more
core +1 more source
, 2023 Supplemental material, sj-docx-1-aut-10.1177_13623613221143587 for Community-guided measurement-based care for autistic youth and adults receiving psychotherapy: A conceptual overview and pilot implementation study of MBC-AUT by Jessica M Schwartzman ...
Zachary J Williams (10907514) +4 more
core +1 more source
Continuous Subcutaneous Foslevodopa/Foscarbidopa in Advanced Parkinson's Disease. [PDF]
Mov Disord Clin PractAbstract Background Continuous subcutaneous foslevodopa/foscarbidopa (LDp/CDp) provides 24‐h delivery of levodopa‐carbidopa prodrugs for advanced Parkinson's disease. Real‐world 1‐year European data remain limited. Objectives To characterize 1‐year changes in motor, non‐motor, autonomic, quality‐of‐life and sleep outcomes, and in concomitant therapy ...
Hero M +5 more
europepmc +2 more sources
sj-docx-1-aut-10.1177_13623613231183059 – Supplemental material for Dropping the mask: It takes two
, 2023 Supplemental material, sj-docx-1-aut-10.1177_13623613231183059 for Dropping the mask: It takes two by Julia M Cook, Laura Crane and William Mandy in ...
Laura Crane (5323148) +2 more
core +1 more source
Frontiers in Chemistry, 2021 Subarachnoid hemorrhage (SAH) is a fatal disease. Within 72 h of SAH, the intracranial blood-brain barrier (BBB) is destroyed, and the nerve cells have responses such as autophagy, apoptosis, and oxidative stress.
Wei Cai +13 more
doaj +1 more source
, 2023 Supplemental material, sj-docx-1-aut-10.1177_13623613231191594 for Autistic adults’ experiences of financial wellbeing: Part II by Elizabeth Pellicano, Gabrielle Hall and Ru Ying Cai in ...
Ru Ying Cai (17104056) +2 more
core +1 more source
Profiling Change of Direction Ability Using Sub-phase 5-0-5 Analysis
International Journal of Strength and Conditioning, 2022 Change of direction (COD) ability is an important component for most field and court sport athletes. The modified 5-0-5 COD test is a commonly used test to measure 180-degree COD performance, the diagnostic value of which can be advanced using a ...
Chloe Ryan +3 more
doaj +1 more source
Aut oppressi serviunt... [PDF]
, 2021 En este volumen analizamos un elemento estructural en la construcción y consolidación del imperio: la relación que establece Roma con las comunidades indígenas, en ocasiones con el empleo de medios coercitivos y en otros con formas de influencia más ...
core
, 2021 Supplemental material, sj-pdf-1-aut-10.1177_13623613211057974 for Deceptive behaviour in autism: A scoping review by Ralph Bagnall, Ailsa Russell, Mark Brosnan and Katie Maras in ...
Mark Brosnan (846335) +3 more
core +1 more source